Siemens Healthineers adds 160,000 shares: Siemens Healthineers stock falls 1.00 percent

Siemens Healthineers (ISIN DE000SHL1006) was trading at EUR 37.50 at Lang & Schwarz on October 5, 2026 at 1:09 p.m. CEST, down 1.00 percent versus the prior close of EUR 37.88. The company bought back 160,000 shares between September 21 and September 27, 2026, according to EQS News on September 28, 2026.

Buyback reaches 3,374,359 shares

The latest purchase lifted the total bought back since June 1, 2026, to 3,374,359 shares. Siemens Healthineers said the transactions were executed on Xetra through a commissioned credit institution, making the program a measurable capital-allocation factor rather than a one-day trading signal.

The September 21 to September 27 purchases carried weighted average prices between EUR 37.19 and EUR 37.75, according to the EQS disclosure. The reference price of EUR 37.50 therefore sits inside the latest weekly acquisition band, while the stock is 24.61 percent above its 52-week low of EUR 32.81 and 24.57 percent below its 52-week high of EUR 49.71 as of October 5, 2026.

Revenue growth supports the valuation

For the fiscal third quarter ended June 30, 2026, Siemens Healthineers generated revenue of EUR 5.76 billion, up 1.80 percent from EUR 5.66 billion a year earlier. Net income reached EUR 669.0 million, an increase of 21.00 percent year over year, while earnings per share rose to EUR 0.60 from EUR 0.49, according to Simply Wall St.

The earnings profile gives the buyback a clearer backdrop: profit growth outpaced revenue growth in the fiscal third quarter. That combination leaves margin development and the pace of future medical-technology demand as key variables for the next valuation step.

JPMorgan sees EUR 57.40 target

JPMorgan kept its Overweight rating and a EUR 57.40 price target after Siemens Healthineers presented its Accela radio-oncology platform, according to finanzen.ch on September 29, 2026. The target lies 53.07 percent above the Lang & Schwarz price, calculated from EUR 57.40 and EUR 37.50.

Siemens Healthineers lists on Xetra under the ticker SHL and is included in the DAX. Its next scheduled reporting date is November 5, 2026, when the company plans to publish fiscal fourth-quarter figures and hold an analyst call, according to its Siemens Healthineers investor-relations page.

Stock remains below its yearly high

At EUR 37.50, the Lang & Schwarz quote is 24.57 percent below the 52-week high of EUR 49.71 and 24.61 percent above the 52-week low of EUR 32.81, both as of October 5, 2026. The further course of trading is shown by the continuously updated real-time quote of Siemens Healthineers stock.

More news and analyses on Siemens Healthineers stock